FINWIRES · TerminalLIVE
FINWIRES

Morgan Stanley Posts 'Strong' Q1 on Trading Strength, Valuation Appears Stretched, Oppenheimer Says

By

Morgan Stanley (MS) reported a "strong" Q1 driven by trading and investment banking, but Oppenheimer said in a note Thursday the stock's valuation appears stretched relative to its historical levels.

Q1 results came in well above its estimates, helped mainly by stronger trading revenue and better investment banking fees, with Morgan Stanley benefiting from strength in equities and select fixed income businesses driven more by business mix than a broader industry shift, Oppenheimer said.

Banking revenue improved sharply, supported by advisory, equity underwriting, and debt issuance. The pipeline remained firm and pointed to a gradual recovery ahead. Expenses were broadly in line with expectations despite higher revenue which reflects cost discipline alongside continued investment in talent and technology.

Morgan Stanley's capital position remained strong, with share buybacks higher than expected and management indicating that potential regulatory changes could be broadly capital neutral.

Oppenheimer kept its perform rating for Morgan Stanley, adding that its current valuation looks elevated relative to history, and said it prefers Jefferies Financial (JEF) over Morgan Stanley for now.

Price: $188.24, Change: $-3.38, Percent Change: -1.76%

Related Articles

Wire

Savara Says FDA Extended Review Period for Molgramostim Inhalation Solution Application

Savara (SVRA) said late Wednesday the US Food and Drug Administration has extended the review period for molgramostim biologics license application in autoimmune pulmonary alveolar proteinosis, a rare lung disease, by three months.The new prescription drug user fee act target action date for the inhalation solution is Nov. 22, the company said.The FDA did not cite any efficacy, safety, or manufacturing concerns, the company said, adding that the FDA determined that the responses to recent information requests represented a significant amendment to the application.

$SVRA
Wire

Euroseas Extends EM Kea Charter for Three Years at Higher Daily Rate

Euroseas (ESEA) extended a charter contract for its feeder containership EM Kea by three years at a gross daily rate of $30,000.The charter is set to begin on July 14 and reflects nearly a 60% increase over the vessel's current rate, the company said Wednesday in a statement.Euroseas expects the charter to generate about $22.5 million in EBITDA over the minimum contracted period.The company's shares fell 2% in after-hours trading.

$ESEA
Wire

Voyager Wins NASA Order for Seventh Private Astronaut Mission to International Space Station

Voyager Technologies (VOYG) said late Wednesday it has signed an order with National Aeronautics and Space Administration for the seventh private astronaut mission to the International Space Station, with a launch planned no earlier than 2028.The mission, dubbed VOYG-1, supports NASA's strategy to shift low-Earth orbit operations to the private sector by enabling commercial partners to deliver human spaceflight services, the company said.

$VOYG